Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

New method of total synthesis of epibatidine reported

Nov. 1, 1996

Lanepitant in clinical trials for pain

Nov. 1, 1996

Dong-A's analgesic drug candidate in clinical trials

Nov. 1, 1996

Glaxo Wellcome anesthetic receives European clearance

Oct. 25, 1996

Novel antimigraine agent launched in the U.K.

Oct. 25, 1996

Antimigraine agents with affinity for 5-HT receptors reported by Pierre Fabre

Oct. 25, 1996

Anesta's Actiq on schedule for launch

Oct. 25, 1996

Neurex broadens clinical program for SNX-111

Oct. 25, 1996

Steroid does not adequately improve symptoms of chronic fatigue syndrome

Oct. 25, 1996

Efficacy of Ampligen demonstrated in chronic fatigue syndrome

Oct. 25, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...